Intuitive Surgical, Inc. (ISRG), iRobot Corporation (IRBT): Robots for the Future

Page 1 of 2

The last time I wrote about Intuitive Surgical, Inc. (NASDAQ:ISRG), I devoted myself to dispelling false fears and shifting the focus to potential issues that could arise in an FDA probe. I now realize that there are a couple of issues that could further weigh on the company’s share price.

Probes can find too much

When a company is subject to regulatory oversight, the regulatory agency has the right to look at everything under its purview. The FDA started a regulatory probe into Intuitive Surgical, Inc. (NASDAQ:ISRG) due to an increased number of reports that something in Intuitive’s robotic da Vinci surgeries went wrong. The reporting standard is extremely broad and even the slightest hiccup is reported. In this case, many of the issues were the cables on the robotic arms breaking, but these can be fixed on site with no damage to the patient. However, as soon as the probe began, Intuitive informed its customers that there was a potential for electrical burns, though no actual proven cases, due to invisible cracks in the surgical scissors on the machines. The last time I wrote about Intuitive I gave very detailed numbers, and the whole point of the reporting system is that the FDA wants to spot potential problems as early as possible. This probe is not something I would consider out of the ordinary, but there is always a risk it will uncover something problematic.

Intuitive Surgical, Inc. (NASDAQ:ISRG)When the FDA looks at the da Vinci system, it doesn’t just look at narrow criteria. Even minor issues could require Intuitive Surgical, Inc. (NASDAQ:ISRG) to do a redesign. A problem could not happen often and when it does not be a big deal, but it could still warrant a redesign without requiring a halt to use. For the patient, this is for the best, but it could be a pain for the company and impact earnings as procedures decline. Any redesign needs to be approved by the FDA and, if the FDA puts a moratorium on new procedures, it could be an extended period of time that Intuitive is not making money off da Vinci procedures.

Wait on Intuitive Surgical, Inc. (NASDAQ:ISRG), because the risk of further losses is substantial. If the FDA asks for more information before coming to a decision, the stock will tumble on fear. Even if the long-term outlook is positive there are short-term gale-force headwinds. The stock recently shot up when Intuitive scored a legal victory. Precedent matters, and one case decided in its favor means that cases that rest on similar grounds should go the same way. However, there are still a lot of obstacles in Intuitive’s way. A positive result from the FDA would probably send the stock up high, but it will probably be too risky for most.

Cleanliness to wellness

iRobot Corporation (NASDAQ:IRBT) is entering the medical robots field with a telepresence device for doctors. This basically allows a doctor who is somewhere else to make visits to patients through the use of a robot that can navigate hospitals and has a large screen and webcam. It seems a bit unnerving, but I see it as a good innovation. The robot could help patients see doctors sooner, even if only electronically. The doctor can log into one machine and see one patient, and then log right into another machine while the first one travels to the next patient.

It will take some time for patients and doctors to get used to the idea. Patients will appreciate being able to see a doctor sooner, but the human touch will be diminished. Additionally, there are significant applications in security, considering that the machine is just a hunk of motion-detecting and scanning equipment. Equip it with the glowing red eyes and you have a great robotic security guard.

These robots are not consumer products, which means pricing pressures are far less than for, say, tablets. There really is no other competition to the telemedicine robot except physical people. Additionally, there will be recurring service income related to the robots, which will help bring more evenness to iRobot Corporation (NASDAQ:IRBT)’s revenue stream. It is still early, but in the consumer goods segment, once the sale is made that tends to be the end of it until replacement time rolls around.

Recent earnings were strong for iRobot Corporation (NASDAQ:IRBT), with the company beating estimates on revenue and earnings. The company closed the year with no long-term debt and cash of $138 million, which is good for a company this size. For now, home robots account for 90% of the company’s revenue, and I will be eager to see telepresence change that. The medical use is the first such use, but there are many other possibilities.

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 44 percentage points in 21 months Learn how!

Lists

The Top 10 States With Fastest Internet Speeds

10 Best Places to Visit in USA in August

Top 10 Cities to Visit Before You Die

Top 10 Genetically Modified Food In the US

15 Highest Grossing Movies Opening Weekend

5 Best Poker Books For Beginners

10 Strategies Hedge Funds Use to Make Huge Returns

Top 10 Fast Food Franchises to Buy

10 Best Places to Visit in Canada

Best Summer Jobs for Teachers

10 Youngest Hedge Fund Billionaires

Top 10 One Hit Wonders of the 90s

Fastest Growing Cities In America

Top 10 U.S. Cities for Freelancers

Top 9 Most Popular Free iPhone Apps

Top 10 Least Expensive Private Business Schools in the US

Top 15 Most Expensive Countries in the World – 2014

Top Businesses to Invest In

Top 5 Things You Might Be Doing Wrong With Your Business

Top 5 Strategic Technology Trends in 2014

Top Rags to Riches Stories

Parenting Behavior That Promotes Future Leaders

Top 5 Mistakes Made by Small Businesses

Top 5 Most Common and Potentially Devastating Financial Blunders

Top 5 Highest Paying Jobs for Web Designers

Top 6 Most Respected Professions that Also Pay Well

Top 5 Pitfalls Investors Should Avoid

Top 6 Lawyers and Policy Makers Under 30

Top 6 New Year’s Resolutions for Entrepreneurs

Top 7 Locations to Check in on Facebook

Top 5 Mistakes made by Rookie eBay Sellers

Top 7 eBook Publishers in 2013

Top 6 Health Industry Trends in 2014

5 Lessons for Entrepreneurs from Seth Godin

Top 5 Success Tips from Jordan Belfort – the Wolf of Wall Street

Best Master’s in Finance Degree Programs

Top 6 Earning Celebrities Over 50

The most expensive sports to play

Top 7 Earning Celebrities Under 25

Best 7 Online Courses to Take: Free Finance MOOCs

Top 6 Bad Habits that Promote Failure

20 Most Valuable Soccer Teams in the World in 2013

12 Most Expensive Countries for Foreign Students

Top 30 Most Influential Women in the World

Top 20 Most Expensive New Year Eve Shows

Top 5 Best Vocational Careers

Top 10 Jobs for 2014 by Salary Gain (Predictions)

Top 5 Digital Trends for 2014

Top 6 Things You Can Do To Increase Your Productivity

Top 9 Trending Smartphones in 2013

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!